Status:

COMPLETED

Impact Of Viagra On Sexual Satisfaction Of Men With Mild Erectile Dysfunction Who Are Sexually Dissatisfied

Lead Sponsor:

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Collaborating Sponsors:

Pfizer

Conditions:

Impotence

Eligibility:

MALE

18+ years

Phase:

PHASE4

Brief Summary

Men's quality of life (QoL) is potentially affected by mild erectile dysfunction (ED) to the same extent as it is by moderate and severe ED. This study will provide controlled clinical data measuring ...

Eligibility Criteria

Inclusion

  • Men above age of majority
  • Mild erectile dysfunction (IIEF-EF 22-25) and sexual dissatisfaction (IIEF-OS 7 or less)

Exclusion

  • Use of more than 4 doses of any PDE5 inhibitor in the past 12 weeks and use of any PDE5 inhibitor in the past 4 weeks
  • Subjects currently taking any other commercially available drug or non-drug treatment for ED

Key Trial Info

Start Date :

November 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2007

Estimated Enrollment :

183 Patients enrolled

Trial Details

Trial ID

NCT00301262

Start Date

November 1 2005

End Date

September 1 2007

Last Update

February 1 2021

Active Locations (26)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 7 (26 locations)

1

Pfizer Investigational Site

Calgary, Alberta, Canada, T2L 1K8

2

Pfizer Investigational Site

Calgary, Alberta, Canada, T2V 4R6

3

Pfizer Investigational Site

Edmonton, Alberta, Canada, T5H 4B9

4

Pfizer Investigational Site

Langley, British Columbia, Canada, V3A 4H9